ranopril 5 mg tabletki
ranbaxy (poland) sp. z o.o. - lisinoprilum dihydricum - tabletki - 5 mg
ranopril 20 mg tabletki
ranbaxy (poland) sp. z o.o. - lisinoprilum dihydricum - tabletki - 20 mg
ranopril 10 mg tabletki
ranbaxy (poland) sp. z o.o. - lisinoprilum dihydricum - tabletki - 10 mg
ivipril 2,5 mg tabletki
bioton s.a. - ramiprilum - tabletki - 2,5 mg
ivipril 5 mg tabletki
bioton s.a. - ramiprilum - tabletki - 5 mg
ivipril 10 mg tabletki
bioton s.a. - ramiprilum - tabletki - 10 mg
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - nowotwory gruczołu krokowego, odpornego Łożysko - terapeutyczne radiofarmaceutyki - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
rozesta 5 mg + 10 mg tabletki powlekane
zentiva, k.s. - rosuvastatinum + ezetimibum - tabletki powlekane - 5 mg + 10 mg